Resistance to the establishment of intestinal Entamoeba histolytica infection is dependent on the inbred mouse strain. In this work we used the inbred strains B6 (resistant), CBA (susceptible), B6CBAF 1 and a backcross of B6CBAF 1 to CBA to further examine the genetic basis of resistance. Mouse genotype was assessed with single nucleotide polymorphism and microsatellite markers and infection assessed by culture 9 days after intracecal E. histolytica challenge. The backcross population showed a male predisposition to culture positivity (Po0.002). F1 genotype at two loci on chromosomes 1 and 2 exhibited suggestive linkage with resistance to infection (P ¼ 0.0007 and 0.0200). Additional suggestive quantitative trait locus were observed on chromosomes 1, 9 and 13 for cecal parasite antigen load and histologic evidence of inflammation. Infection in C3H Â B6 recombinant inbred mice supported the mapping data. Candidate B6 genes on chromosomes 1 and 2 were examined by microarray analysis of epithelial tissues from B6 vs CBA mice. This work shows a male predisposition to intestinal amebiasis and suggests that relatively few B6 loci can confer resistance in inbred mice. Future identification of regional candidate genes has implications for understanding the human variability to amebic infection.
Introduction
Entamoeba histolytica is the agent of amebic colitis and liver abscess and is responsible for a global mortality burden, second only to malaria, among parasitic diseases. 1 However not all infections result in disease. Bangladeshi children with similar exposure risk exhibit significant variability in susceptibility to both colonization and invasive infection. 2, 3 Other reports confirm a colonization rate of up to 8% in endemic areas, yet only approximately 9% of colonized individuals develop symptoms. [4] [5] [6] For unknown reasons male gender appears to predispose toward progression to invasive disease, both colitis and liver abscess, but has a neutral effect on colonization rates. 7 Mechanisms of human resistance to the parasite have largely been studied at the adaptive immune level and show associations between fecal immunoglobin A and parasite-specific interferon gamma production with resistance to subsequent diarrheal episodes. 2, 8, 9 Comparatively little is known about mechanisms that protect against primary infection in the gut.
We have used a mouse model of intestinal amebiasis that is informative of this initial infection event.
Intracecal inoculation of trophozoites 8, 10, 11 leads to patent infection and inflammation in certain strains of mice such as CBA or C3H (either TLR4 mutant or wild-type) while several other inbred mouse strains including B6 are highly resistant to infection, clearing trophozoites within hours. This timing suggests that B6 resistance is innate, or perhaps more appropriately termed 'natural,' because it occurs with relatively little histologic change and does not require an intact inflammatory response (for example, it is seen in severe combined immunodeficiency disease (SCID), IL-12p40 deficient, inducible nitric oxide synthase deficient, phagocyte oxidase deficient, MyD88 deficient or neutrophil-depleted B6 mice). 10, 11 Bone marrow chimera experiments have shown that the resistance vs susceptibility of B6 vs CBA mice to this infection track with the strain's nonhematopoietic cells, 12 suggesting the host's epithelium governs this phenotype. Overall we conceptualize B6 mice as endowed with an inherently resistant epithelial response to the parasite, while that of the CBA is permissive to infection. One hypothesis is that B6 mucosa is deficient in binding to the parasite or its adhesin. Another hypothesis is that B6 epithelial cells undergo a phenotypically distinct and protective program upon interaction with the parasite. In this work we could not readily observe a defect in parasite adherence to the B6 mucus layer and therefore pursued potential B6 resistance genes through comparison of B6, CBA, B6CBAF 1 and N 2 backcross mice. To our surprise this work incidentally identified an effect of gender on primary susceptibility.
Results
B6 resistance is not associated with diminished parasite adherence to mucus layer E. histolytica trophozoites initiate infection by adhering to colonic mucus through the parasite's galactose/N-acetyl-D-galactosamine inhibitable (Gal/GalNAc) lectin. 13, 14 We therefore sought to examine the hypothesis that B6 resistance was contributed by dysfunctional parasite adherence to cecal mucus. First we examined binding of purified E. histolytica Gal/GalNac lectin to cecal mucus and epithelium between strains but there were no apparent differences by histochemistry ( Figure 1a ). Next we preincubated intestinal washes from CBA and B6 mice with the ameba but found no alteration in strain susceptibility upon subsequent challenge (culture positivity rates 9 days post-challenge 1/17, 1/16, 11/30 and 11/27 for B6 mice injected with ameba incubated with B6 washes, B6 mice/CBA washes, CBA mice/B6 washes and CBA mice/CBA washes; Po0.03 for mouse strain, P ¼ NS for intestinal washes). Finally we examined susceptibility of B6 mice deficient in Muc2, the most abundant secreted mucin in the colon 15 and known to prevent E. histolytica adherence in vitro. 16 For such experiments on the resistant B6 background we killed the mice at 3 days post-challenge to look for evidence of ameba histologically, however the Muc2KO mice remained resistant to wild-type levels, with ameba or inflammation rarely seen (Figures 1b and c) . backcross N 2 mice exhibit intermediate  susceptibility to amebiasis and show a male predisposition  to infection As we could not demonstrate any obvious role for differential adherence to intestinal mucus between strains, we undertook a less biased forward approach to identify genetic loci associated with B6 resistance to primary infection. First we examined susceptibility in F1 mice and found that B6CBAF 1 mice (offspring of a B6 female Â CBA male cross) or the reciprocal CBAB6F 1 mice were resistant (infection rate ¼ 2/28 and 0/6, respectively, based on culture 1 week after challenge, with no difference between males or females) indicating that resistance was dominant and susceptibility recessive.
In order to map B6 loci that confer resistance, we generated N 2 mice using a cross between B6CBAF 1 female and CBA male mice. To efficiently examine the genetics of susceptibility with the fewest numbers of mice, all cohorts shown in the experiments of Figure 2 were pretreated with dexamethasone because this maneuver raises the susceptibility of CBA mice (from B60 to B95%) but has little effect on B611 or F1 mice (for example, B6CBAF 1 infection rate ¼ 5/23 and CBAB6F 1 infection rate ¼ 2/24 with dexamethasone, compared to Genetic control of resistance to E. histolytica S Hamano et al B6CBAF 1 infection rate ¼ 2/28 and CBAB6F 1 infection rate ¼ 0/6, P ¼ NS; no difference between males or females, data not shown). N 2 mice (117) were intracecally challenged with E. histolytica trophozoites and killed after 9 days. Of these 117 N 2 mice, 36 exhibited patent E. histolytica infection by cecal culture (infection rate, 31%). We detected a significant difference in infection rate between males and females in this N 2 population (27/62 male mice infected vs 9/55 female mice; P ¼ 0.002). Additionally, infected male mice had a higher parasite burden than infected females according to enzymelinked immunosorbent assay (ELISA; 0.54 ± 0.11 vs 0.16 ± 0.11, P ¼ 0.04; n ¼ 27 and 9). Thus far we have not documented a male effect on infection rate in the pure CBA, B6 or F1 strains, perhaps due to sample size issues, however we have observed a significant male predisposition in the FVB strain (for example, 15/18 FVB males infected vs 10/25 females based on culture 5 days postchallenge with no dexamethasone pretreatment; Po0.05).
This infection rate of 42% in male N 2 mice suggested that relatively few co-inherited B6 alleles could impart resistance (for example, 1 or 2 genes should impart B25 or B50% infection rate, respectively, given 0% infection rate in B6 male and 100% in CBA male). Likewise, the low infection rate of 15% in female N 2 suggested that several CBA genes must be inherited for susceptibility in females.
Loci on chromosomes 1 and 2 correlate with resistance to intestinal amebiasis In order to examine candidate B6 genes that could impart resistance in the N 2 population, we fixed the CBA Y chromosome and compared the 27 infected vs 25 uninfected N 2 males by whole-genome scan (Table 1) . Figure 3b ). Likewise, suggestive linkage existed for most of the chromosome 2 region between rs3022884/ 54 417 652 bp and rs3662211/129 970 691 bp (c2 ¼ 5.26, P ¼ 0.0109 and c2 ¼ 7.00, P ¼ 0.0041, respectively; Figure 3b ). Additionally, suggestive linkage persisted for both chromosomes 1 and 2 loci when all 117 mice including females were added to the analysis: proximal chromosome 1 rs3684370/16 188 620 bp (c2 ¼ 8.83, P ¼ 0.001) and middle chromosome 2 rs3022884/54 417 652 bp (c2 ¼ 6.48, P ¼ 0.005).
The effects of the chromosomes 1 and 2 alleles appeared to be additive. In particular, only 17% of the N 2 mice homozygous for CBA alleles at both loci were resistant ( Figure 3c ). N 2 mice of F1 genotype at either chromosome 1 (rs3684370/16 188 620) or chromosome 2 (rs3662211/129 970 691 bp) loci exhibited intermediate levels of resistance (46 and 36%, respectively) while N 2 mice of F1 genotype at both loci were highly resistant (94%; Pp0.01 vs other groups).
Genetic determinants for levels of ameba antigen and inflammation scores While susceptibility to the establishment of infection (culture positive Y/N) is the simplest and most fundamental phenotype of this model we also performed quantitative trait locus (QTL) analysis of N 2 mice for the continuous variables of cecal amebic antigen and histologic inflammation score. Based on significance thresholds determined by permutation analysis (5000 replicates), our genome-wide scan of N 2 mice revealed suggestive QTLs for cecal antigen within the chromosome 1 region (rs3024171/6 479 671 bp and rs3684370/16 188 620 bp, Effect of B6 alleles on chromosomes 1 and 2 loci on amebic infection in vivo We next sought to validate our mapping results on chromosomes 1 and 2 using genotypically defined mice. Although no defined recombinant inbred or consomic panels are available for the CBA/B6 strain combination, we were able to obtain recombinant inbred mice derived from progenitor strains C3H/HeJ and B6 (BXH). The C3H and CBA strains are both susceptible in our model and are genetically similar, derived from the same 1920 cross between a Bagg albino female and a DBA male. 17 The BXH14/TyJ mouse is homozygous for C3H/HeJ alleles throughout the entire identified chromosome 1 and most of the chromosome 2 loci. For these studies no dexamethasone was administered which could confound effects on host genes. Given the known high-level resistance of B6 mice, these experiments were shortened to 24 h post-challenge and numbers of ameba was assessed by histology, a more discriminatory measure than culture or antigen at such an early time point. 12 Ameba score indicated that BXH14/TyJ mice were similarly susceptible to infection as C3H mice by this measure (P ¼ NS vs C3H, P ¼ 0.01 vs B6; Figure 4) , compatible with the notion that the chromosomes 1 and 2 loci are relevant.
Candidate genes at chromosomes 1 and 2 loci Based on our previous findings that infection in this model is limited to the cecum and that mouse strain resistance tracks with nonhematopoietic cells, 12 a Genetic control of resistance to E. histolytica S Hamano et al possible hypothesis is that genetic control of resistance resides at the level of the cecal epithelium. As genetic differences between CBA and B6 may be observable at the level of transcription we examined mRNA expression by microarray in stripped cecal epithelial tissues from naive CBA and B6 mice. Of 45 037 genes or expressed sequence tags probed with the Affymetrix MOE430 2.0 arrays, 954 were found to be differentially regulated in these two strains using a conventional D-chip analysis. Among genes with dysregulated expression more than 1.75-fold, 28 candidates localized to the relevant regions on chromosomes 1 or 2 (shown in Table 2 ). The expression of several upregulated B6 'resistance' candidate genes Ctdspl2, Trp53bp1 and Spata5l1 and upregulated CBA 'susceptibility' candidate genes Tmtm87a and Pldn showed consonant results by reverse transcriptase (RT)-PCR, per the validation methodology of Miron et al. 18 ( Supplementary Figure 1 , correlation coefficient ¼ 0.80, P ¼ 0.028). Full access to the microarray data including candidate genes at chromosomes 4, 7, 9, 13, and 17 can be found at https:// genes.med.virginia.edu/public_data/index.cgi under 'Eric_Houpt_CBAvsB6naive'.
Discussion
The first clear finding from this work is that male gender can predispose toward intestinal amebiasis in mice, linking this mouse model strongly to human disease where male predominance has been repeatedly noted. The second finding from the backcross studies is that murine resistance to infection with E. histolytica may be imparted by relatively few genetic loci. Third, suggestive loci that associate with the initial infection rate were distinct from those of parasite burden and inflammation severity, suggesting that these phenomena may be under distinct host control.
Demonstration of a male predisposition to amebiasis was clearly dependent on the strength of the genetic susceptibility, with its effects only clearly seen in animals with inheritance of some resistance alleles. In the N 2 mouse population, male sex was associated with increases in both infection rate (culture positivity) and parasite burden once infected. A male increase in infection rate was also observed with the inbred FVB strain, but has not been seen in the strongly susceptible C3H or CBA or the resistant B6, presumably because sex chromosome-independent effects predominate in these strains. Although likely simplistic, we presently conceptualize the infection rate (culture positivity) as informing the event of colonization, while parasite burden and inflammation scores are measures of the severity of invasive disease. If this model is accurate, the latter finding of increased parasite burden in male mice is particularly supportive of the long-appreciated clinical finding that men are more predisposed to severe invasive amebiasis than women. The male predisposition to invasive amebiasis is striking and worldwide, with a male:female ratio of up to 7:1 for both colitis and liver abscess in several studies. 7 Mechanisms are unclear, however a male predominance has also been observed in a B6 mouse model of amebic liver abscess where it can be traced to a diminished innate interferon-g response. 19 In other intestinal infection models such as Campylobacter, Helicobacter and Strongyloides, 20-24 a male predominance has also been observed and has been attributed broadly to testosterone effects.
Another important finding from this work was the suggestive association between B6 alleles on chromosomes 1 and 2 and resistance to parasite establishment in the gut. It is unclear whether such B6 loci actively confer resistance or whether CBA loci actively support the colonization of ameba in the gut, and that this permissiveness is then lost by default by replacement with B6 loci. One could argue the latter, that susceptibility is the abnormal phenotype and resistance is default, given previous work that shows the relative lack of an active histologic inflammatory response in B6 mice and their persistent resistance despite maneuvers to ablate inflammation. 10, 11 As such, one would be interested in the pathologic role of upregulated epithelial CBA transcripts at the chromosomes 1 and 2 loci such as Tmem87a or Pldn, which unfortunately are presently undescribed (Table 2) .
Alternatively one could argue that the presence of particular B6 genes could still actively confer resistance (for example, with minimal induction of inflammation) such as through control of production of an antimicrobial peptide. This would drive interest in the potential resistance functions of the upregulated B6 genes known to be involved in epithelial immunity (Table 2) . Certainly lymphocyte antigen 96 (Ly96; MD-2) is an interesting candidate given its role in upregulating signaling through TLR4, 25 to which E. histolytica is known to bind. 18 However B6 resistance has not required MyD88, 11 therefore this candidate loses some enthusiasm, or one would need to invoke TRIF/MyD88-independent mechanisms of TLR4 activation. 26 Transformation related p53 binding protein 1 was the most upregulated annotated B6 gene in the epithelium vs CBA (501-fold by microarray) and has been shown in other models of gut injury to function in maintaining DNA stability, 27 thus a possible role for this molecule in intestinal amebiasis could be envisioned. Other B6 transcripts of potential interest include apoptosis-related genes such as the proapoptotic gene BCL2-like 11. Epithelial apoptosis could be predicted to be either Genetic control of resistance to E. histolytica S Hamano et al Figure 1) .
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protective or deleterious during amebiasis. In a SCID mouse model of amebic liver abscess, hepatocyte apoptosis plays a pathologic role in abscess formation. 28 In contrast in intestinal helminth models epithelial apoptosis is thought to be protective by maintaining crypt length and epithelial homeostasis. 29 Beyond these chromosomes 1 and 2 loci that associate with resistance to the establishment of infection, the presence of other loci that associate with parasite burden once infected (chromosome 13) and the resultant inflammatory response (chromosome 9) suggest the presence of multiple layers of host control in amebiasis. The LRS scores for these loci were modest and should not be overinterpreted in the absence of confirmatory evidence in congenic or recombinant inbred strains. However the concept of sequential nodes of host control is in keeping with our working understanding of this model, which holds that amebic infection proceeds through multiple phases, step one being parasite survival amid the epithelium and step two being survival amid the inflammatory response. Therefore the possibility of distinct genetic loci that associate with these two steps was anticipated. As the mouse genome becomes annotated and whole genome association studies unfold from human amebiasis sites 9 it is hoped that findings such as these can be directly tested to shed light on the pathogenesis of this disease.
Materials and methods
Mice C57BL/6, CBA/J, B6CBAF 1 (B6 Â CBA) and BXH14/TyJ mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA). FVB mice were obtained from Craig Coopersmith (Washington University, St Louis, MO, USA). Muc2 KO mice were obtained from Anna Velcich (Albert Einstein Cancer Center/Montefiore Medical Center, New York, NY, USA) and tested against wildtype littermates. N 2 mice were bred by backcrossing B6CBAF 1 female with CBA/J male mice. Animals were maintained under specific pathogen-free conditions at the University of Virginia and were challenged at 4-8 weeks of age. The Institutional Animal Care and Use Committee approved all protocols. Recombinant inbred strain BXH14/TyJ contains unique, approximately equal proportions of genetic contributions from two progenitor C3H/HeJ and C57BL/6J inbred strains and is, importantly, homozygous for C3H/HeJ at whole chromosome 1 and the latter half of chromosome 2 (http://www.well. ox.ac.uk/mouse/INBREDS/RIL/BXH.shtml).
Parasites and intracecal inoculation
Trophozoites for intracecal injections were originally derived from laboratory strain HM1:IMSS (American Type Culture Collection, Manassas, VA, USA) that have been sequentially passaged in vivo through the mouse cecum. Cecal contents were cultured in trypsin-yeast-iron (TYI-S-33) medium supplemented with 25 U ml À1 penicillin and 25 mg ml À1 streptomycin. For all intracecal inoculations, trophozoites were grown to the log phase, counted with a hemacytometer and 2 Â 10 6 trophozoites in 150 ml were injected thrice intracecally after laparotomy as described. 10 For select experiments dexamethasone was administered to mice 0.2 mg i.p. on days À3, À2, À1 and 0 to enhance susceptibility of CBA mice. For cecal wash experiments, cecal mucinous intestinal washes were prepared by flushing cecal contents with completed TYI media and centrifuging at 14 000 g Â 10 min (simplified from Carlstedt et al.
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). Supernatant was incubated 1:1 with an E. histolytica pellet of 2 Â 10 6 trophozoites at 37 1C for 1 h and ameba were then injected intracecally.
Pathology and scoring of amebic colitis Mice were killed and each cecum longitudinally bisected. One half of the cecum was placed in Hollande's fixative, cut into 3-5 equal cross sections, paraffin embedded and 4 mm sections were stained with hematoxylin and eosin. Histopathology was scored in blinded fashion for inflammation score and ameba score for each mouse as described previously. 16 To determine infection rate by culture, the contents of the other half of the cecum were rinsed in 1 ml phosphate-buffered saline (PBS) and cultured in TYI-S-33 medium. To determine infection severity 200 ml of this material was tested for E. histolytica antigen by ELISA (E. histolytica II test, Techlab, Blacksburg, VA, USA). ELISA values were normalized for background and positive control optic density.
Lectin histochemistry Purified E. histolytica Gal/GalNAc lectin was prepared as previously described.
14 Frozen acetone-fixed sections of cecal tissue were stained with or without 20 mg lectin per ml Â 30 min at room temperature, followed by 12 mg ml À1 rabbit polyclonal anti-E. histolytica Gal/GalNAc lectin antibody Â 30 min at room temperature, followed by biotinylated goat anti-rabbit immunoglobin G, ABC working solution and diaminobenzidine (Vector, Burlingame, CA, USA) as per the manufacturer's instructions. The identical protocol without Gal/GalNAc lectin was performed as control.
Genotyping
Genomic DNA was isolated from the tails and livers of mice by using the standard phenol/chloroform extraction and ethanol precipitation method. A total of 150 markers with 32 microsatellites and 118 single nucleotide polymorphisms, distinguishing B6 from CBA strain and covering all 19 autosomes and the X chromosome, were used to identify which of the two parental strains contributed to alleles at a specific locus of each N 2 mouse (Table 1 ). Parental and F 1 DNA served as control for each marker. The linkage maps and marker positions reported were determined using our own data and Map Manager.
Epithelial microarrays
Affymetrix gene chip analysis was performed according to the manufacturer's instructions using murine MOE430 2.0 arrays. Full public access to the raw data is available at https://genes.med.virginia.edu/public_data/index. cgi under 'Eric_Houpt_CBAvsB6naive'. Information about a microrarray experiment (www.mged.org/ miame) includes the following. Ceca were obtained from male 6-week-old CBA/J and B6 mice (n ¼ 3 each). Cecal contents were rinsed in sterile PBS and the cecal wall was scored, and serosal and muscularis layers were removed. Mucosal epithelial tissues were then placed in RNAlater (Ambion, Austin, TX, USA), homogenized and total RNA extracted using the RNAEasy kit (Qiagen, Valencia, CA, USA). Ribosomal peaks were intact and showed no evidence of degradation. The BioB control cRNA was spiked in at the detection threshold of 1.5 pM and received a 'present' detection call. Housekeeping genes had 3 0 -5 0 detection ratios of o4. Complementary DNA synthesis, in vitro transcription to cRNA and hybridization were performed as per http://www.healthsystem. virginia.edu/internet/biomolec/microarray.cfm.
Raw data from the arrays was normalized at probe level using gcRMA algorithm. The detection call (Present, Marginal, Absent) for each probe set was obtained using the GeneChip Operating Software system. CBA/J vs B6 groups were compared using dChip software, whereby gene expression was deemed significantly different if the P-value was less than or equal to 0.05, the fold change in signal intensity was 41.75 or oÀ1.75, and the absolute difference in signal intensity was 4100.
RT-PCR Quantitative RT-PCR was used to validate changes in a subset of genes from microarray selection from each of the three CBA and three B6 RNA samples. RT-PCR primers were designed using Primer3 based on the published 3 0 sequence as per Affymetrix. The primers used were glyceraldehyde-3-phosphate dehydrogenase (GAPDH): forward, GCTAAGCAGTTGGTGGTGCA and reverse, TCACCACCATGGAGAAGG; BCL2-like 11 apoptosis facilitator (Bcl2l11): forward, TCCTATTTCC TTCCAGTGTTGT and reverse, GGGAACACAATTGCA CAGAG; lymphocyte antigen 96 (Ly96): forward, CTTTTCGACGCTGCTTTCTC and reverse, CCATGGC ACAGAACTTCCTT; transformation related protein 53 binding (Trp53bp1): forward, AGTCCTGAGACAGA GGCCAGT and reverse, GTGTGGGTGCCACAGAGGT; transmembrane protein 87A (Tmem87a): forward, TGT GGTGCACACTCCAAAA and reverse, TAAGCTCCCC TTCTGAAGCA; pallidin (Pldn): forward, GCAGCTCA CAGCCATCTGTA and reverse, TTAGGGCTTCATCA CCTATGG; carboxy-terminal domain, RNA polymerase II, polypeptide A (Ctdspl2): forward, GAGAGCCCAAT GATTAGCAA and reverse, CAGCAACAAAATAATTA TAAAGTCAGA; spermatogenesis associated 5-like 1 (Spata5l1): forward, CGGCCTGGAAGATTAGATAAGA and reverse, CACAGTCTTGAGTGCTTCTGTG. GAPDH was used as the internal control. Real-time PCR was conducted using iQ SYBR Green SuperMix (Bio-Rad, Hercules, CA, USA) on an Bio-Rad iCycler. Target gene amplification was quantified as the reciprocal log 2 of the DC(t) between GAPDH and the target gene.
Statistics
Genetic markers were assigned to and mapped within the chromosomes using multipoint linkage analysis with Map Maker QTXb20. Genome-wide interval mapping for amebic antigen load measured by ELISA and inflammation score was performed using QTX software to identify QTLs. All QTL mapping methods offered by QTX generate a LRS as a measure of the significance of a possible QTL. 31 The LRS approaches a w 2 -statistic with large sample sizes. Single-locus associations were tested by simple regression analysis between trait values and genotypes and the significance of each potential association was measured using the LRS. A total of 5 000 permutations of the trait values were used to define the genome-wide LRS threshold required to be significant or suggestive for each specific trait. Loci exceeding the 95th percentile of the permutation distribution were defined as significant (Po0.05) and those exceeding the 37th percentile were suggestive (Po0.63). 32 Statistical significance for infection rate was determined by Fisher's exact test. Means were compared using t-test or MannWhitney test if data were not gaussian. RT-PCR differences were determined using unpaired Student's t-test. Fold changes between RT-PCR and microarray were compared using linear regression analysis using Pearson's R correlation.
